DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Dinuclear silver and gold bisNHC complexes as drug candidates for cancer therapy
We report four dinuclear silver(I) and gold(I) complexes containing two different bidentate N-heterocyclic carbene ligands (bisNHC). One of these complexes 4, shows strong and selective anticancer activity against the human ovarian cancer cell line A2780. Mechanistically, 4 enhances the oxidative stress by stimulating reactive oxygen species production and inhibiting the scavenging activity of thioredoxin reductase. Our findings provide evidence that tuning ligand and electronic properties of metal-NHC complexes can modulate their reactivity and selectivity and it may result in potential novel anticancer drugs., We acknowledge financial support from Ministerio de Ciencia e Innovación, Spain (RTI2018-096323-B-I00), the Marie Curie Career Integration Grants (PCIG12-GA-2012-33835), the Max Planck Society (MPG Partner Group), the Aragon Government (E42_20R) and the University of Zaragoza., Peer reviewed
DOI: http://hdl.handle.net/10261/271149, https://api.elsevier.com/content/abstract/scopus_id/85130351392
HANDLE: http://hdl.handle.net/10261/271149, https://api.elsevier.com/content/abstract/scopus_id/85130351392